Contact us

Case Study / Medical Affairs and Communications

Measured Approach to Launch Excellence

Created - Wednesday, September 9, 2026

Challenge

A top-5 pharmaceutical company faced 7 near-term launches across 6 priority therapy areas, followed by 20 additional entrants and 30 line extensions over four years, all while bracing for major Loss of Exclusivity events. With this level of portfolio complexity, ad hoc launch preparation was no longer sufficient. The organization needed a stronger, more consistent approach to launch readiness that could scale across brands and protect market momentum.

Solution

OPEN Health built a replicable, insight-driven launch readiness framework grounded in three inputs: internal analogues distilling lessons from previous portfolio launches into repeatable readiness standards; external analogues drawing on industry benchmarks and best-practice models; and targeted subject matter expertise to accelerate cross-functional alignment. Together, these elements created a scalable blueprint enabling earlier preparation, clearer decision-making, and more predictable launch outcomes across the portfolio.

Outcome

With a consistent, evidence-based framework in place, brand teams could identify readiness risks earlier and resolve them before they became launch liabilities. Cross-functional alignment improved significantly, reducing the inconsistency that had previously exposed individual launches to avoidable delays. The organization entered its most complex launch period with the agility and visibility needed to protect growth and absorb LOE pressure without sacrificing market momentum.

Working on something similar?

Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference.

For information about OPEN Health’s services and how we could support you, please get in touch.